How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

267,327 results for

Risk Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer

Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer canceraustralia.gov.au Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer This resource is for all members of the multidisciplinary shared care team. It provides guidance on the screening, assessment and management of supportive care needs of women affected by low-risk (...) for women with low-risk endometrial cancer: A guide for General Practitioners. Surry Hills, NSW: Cancer Australia; 2019. 2. Ward KK, Shah NR, Saenz CC et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012;126(1):176–9. 5. Cancer Australia. Follow-up care for women with low-risk endometrial cancer: A guide for General Practitioners. 2019. Supporting self-management and living well Provides guidance to women, promoting health and wellbeing, self

2020 Cancer Australia

2. Health workers exposure risk assessment and management in the context of COVID-19 virus

Health workers exposure risk assessment and management in the context of COVID-19 virus -1- Risk assessment and management of exposure of health care workers in the context of COVID-19 Interim guidance 19 March 2020 Current evidence suggests that the virus that causes COVID-19 is transmitted between people through close contact and droplets. People most at risk of acquiring the disease are those who are in contact with or care for patients with COVID-19. This inevitably places health care (...) ? Occasionally ? Rarely - 4. Disposable gown ? Always, as recommended ? Most of the time ? Occasionally ? Rarely Risk assessment and management of exposure of health care workers in the context of COVID-19: Interim guidance -4- B. During a health care interaction with the COVID-19 patient, did you remove and replace your PPE according to protocol (e.g. when medical mask became wet, disposed the wet PPE in the waste bin, performed hand hygiene, etc.)? ? Always, as recommended ? Most of the time ? Occasionally

2020 WHO Coronavirus disease (COVID-19) Pandemic

3. Asthma and COVID-19: risks and management considerations

Asthma and COVID-19: risks and management considerations Asthma and COVID-19: risks and management considerations - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Asthma and COVID-19: risks and management considerations May 28, 2020 Jamie Hartmann-Boyce 1 Afolarin Otunla 2 Jonny Drake 2 Jana Suklan 3 Ella Schofield 2 Jade Kinton 2 James Gunnell 2 Andrew Menzies-Gow 4 Matt Inada-Kim 5 Richard Hobbs 1 (...) if people with asthma are at increased risk of contracting COVID-19 or of worse outcomes from COVID-19 infection. The evidence available is limited with some sources suggesting an underrepresentation of PWA in hospitalised cases, and others showing an increased risk of worse outcomes in PWA which may be associated with disease severity. Consensus broadly holds that asthma medications should be continued as usual. Asthma care may be disrupted during the pandemic; self-management and remote interventions

2020 Oxford COVID-19 Evidence Service

4. Shared follow-up and survivorship care for low-risk endometrial cancer: Supporting self-management and living well

Shared follow-up and survivorship care for low-risk endometrial cancer: Supporting self-management and living well canceraustralia.gov.au Supporting self-management and living well This resource is for women who have completed treatment for low-risk endometrial cancer. It provides general information and guidance on living well following treatment. What might I experience after completing treatment? Some women experience side effects and issues that continue after the completion of treatment (...) Practitioner (GP) and primary health care nurse) as they will be able to provide support and advice and a referral to another service or health professional if required. SHARED FOLLOW-UP AND SURVIVORSHIP CARE FOR LOW-RISK ENDOMETRIAL CANCER Supporting self-management and living well How can I maintain my health and wellbeing? Here are some simple recommendations to help you maintain your overall health and wellbeing. Discuss with your primary care team ways to develop lifestyle changes through a balanced

2020 Cancer Australia

5. Risk reduction and management of delirium

Risk reduction and management of delirium Risk reduction and management of delirium A national clinical guideline March 2019 SIGN157Key to evidence statements and recommendations Levels of evidence 1 ++ High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 1 + Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias 1 – Meta-analyses, systematic reviews, or RCTs with a high risk of bias 2 ++ High-quality systematic reviews of case (...) term is valid until 31 March 2020 and is applicable to guidance produced using the processes described in SIGN 50: a guideline developer’s handbook, 2015 edition (www.sign.ac.uk/assets/sign50_2015.pdf). More information on accreditation can be viewed at www.nice.org.uk/accreditationRisk reduction and management of delirium A national clinical guideline March 2019 Scottish Intercollegiate Guidelines NetworkScottish Intercollegiate Guidelines Network Gyle Square, 1 South Gyle Crescent Edinburgh EH12

2019 SIGN

6. Best practices for managing sleep in intensive care patients to reduce the risk of delirium

Best practices for managing sleep in intensive care patients to reduce the risk of delirium Best practices for managing sleep in intensive care patients to reduce the risk of delirium We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Best practices for managing sleep in intensive care patients to reduce the risk of delirium Share: Reading time approx (...) contribute to the development of delirium. Disturbed sleep is an additional important factor. Question Which practices for sedation in intensive care result in adequate sleep and reduced risk of delirium? The complete Enquiry response is published in Swedish. Click on ”På svenska” in the top menu to read it. SBU Enquiry Service consists of systematic literature searches to highlight studies that can address questions received by the SBU Enquiry Service from Swedish healthcare or social service providers

2018 Swedish Council on Technology Assessement

7. Blood-borne viruses: managing potential risk in emergency workers

Blood-borne viruses: managing potential risk in emergency workers Blood-borne viruses: managing potential risk in emergency workers - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Blood-borne viruses: managing (...) potential risk in emergency workers Information on preventing and controlling the exposure of emergency service personnel to common blood-borne viruses. Published 4 October 2019 From: Documents Ref: PHE publications gateway number: GW-747 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document contains

2019 Public Health England

8. Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient

Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient 1 Public Summary Document Application No. 1515 Endoscopic placement and removal of an intragastric balloon for the management of moderate obesity in patients with type 2 diabetes mellitus who have failed first-line treatments Applicant: Apollo Endosurgery Australia Date of MSAC consideration: MSAC 76 th Meeting, 1-2 August 2019 Context for decision: MSAC makes (...) Endosurgery Australia by the Department of Health. 2. MSAC’s advice to the Minister After considering the strength of the available evidence in relation to comparative safety, clinical effectiveness and cost-effectiveness, MSAC did not support public funding for endoscopic placement and removal of an IGB for the management of moderate obesity in patients with poorly controlled T2DM who have failed first-line treatments. MSAC considered that IGB had inferior safety (relative to lifestyle interventions

2019 Medical Services Advisory Committee

9. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline EndoscopicmanagementofLynchsyndromeandof familialriskof colorectalcancer:EuropeanSocietyofGastrointestinalEndoscopy (ESGE) Guideline Authors MoniqueE. vanLeerdam 1,2 ,VictorineH.Roos 3 ,JeaninE.vanHooft 3 ,FrancescBalaguer 4,5 ,EvelienDekker 3 ,MichalF. Kaminski 6,7,8 ,AndrewLatchford 9,10 ,HelmutNeumann 11 ,LuigiRicciardiello 12 ,MariaRupinska 6,7 (...) ]. Among CRC cases about 2%–4% are caused by LS [4]. As well as increased CRC risk, individuals with LS have a higher risk of developing endometrial, gastric, small- bowel,biliarytract,ovary,urinarytract,brain,andskincancers. Because of the high cancer risk, it is of great importance that clinicians recognize individuals with LS in order to make appro- priate management decisions for both the patient and their at- risk family members. CRC cases associated with polyposis syn- dromes are discussed

2020 European Society of Gastrointestinal Endoscopy

10. The screening and management of newborns at risk for low blood glucose

The screening and management of newborns at risk for low blood glucose Hypoglycemia in the first hours to days after birth remains one of the most common conditions facing practitioners across Canada who care for newborns. Many cases represent normal physiologic transition to extrauterine life, but another group experiences hypoglycemia of longer duration. This statement addresses key issues for providers of neonatal care, including the definition of hypoglycemia, risk factors, screening (...) protocols, blood glucose levels requiring intervention, and managing care for this condition. Screening, monitoring, and intervention protocols have been revised to better identify, manage, and treat infants who are at risk for persistent, recurrent, or severe hypoglycemia. The role of dextrose gels in raising glucose levels or preventing more persistent hypoglycemia, and precautions to reduce risk for recurrence after leaving hospital, are also addressed. This statement differentiates between

2019 Canadian Paediatric Society

11. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT)

Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) - Regan - - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term RCOG Scientific Impact Paper Free Access Prenatal Management of Pregnancies (...) detected antibodies in Caucasians are those directed against human platelet antigen (HPA)‐1a (80%) and HPA‐5b (10–15%), which can allow prediction of at‐risk fetuses. Where results are not supportive but clinical suspicion of FNAIT is high, further testing and management should be discussed with the diagnostic laboratory. The prenatal management of FNAIT has undergone a major shift over the past few years. There has been an increase in the use of immunoglobulins following evidence of probable efficacy

2019 Royal College of Obstetricians and Gynaecologists

12. Strategies For Risk Reduction and Management of Older Adults With Cardiovascular Disease During the COVID-19 Pandemic

Strategies For Risk Reduction and Management of Older Adults With Cardiovascular Disease During the COVID-19 Pandemic Strategies For Risk Reduction and Management of Older Adults With Cardiovascular Disease During the COVID-19 Pandemic - American College of Cardiology ') Search All Types Search or Menu . This article was authored by Nicole M. Orr, MD, FACC , and the Geriatric Cardiology Council. Share via: Clinical Topics: Keywords: Aged, SARS Virus, Angiotensin Receptor Antagonists (...) , Hydroxychloroquine, Mineralocorticoid Receptor Antagonists, Caregivers, Angiotensin-Converting Enzyme Inhibitors, COVID-19, Coronavirus, Coronavirus Infections, Neprilysin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Neprilysin, Chloroquine, Subacute Care, Social Isolation, Skilled Nursing Facilities, Cardiovascular Diseases > > Strategies For Risk Reduction and Management of Older Adults With Cardiovascular Disease During the COVID-19 Pandemic Heart House 2400 N Street NW Washington, DC 20037 Phone: , ext

2020 American College of Cardiology

13. Suicide risk management

Suicide risk management Suicide risk management - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Suicide risk management Last reviewed: February 2019 Last updated: June 2018 Summary Suicide is the thirteenth leading cause of death worldwide, with about 1 million deaths every year due to self-inflicted violence. In people aged 15 to 44 years, self-inflicted injury is the fourth leading cause of death and the sixth (...) leading cause of ill health and disability worldwide, making suicide a significant public health concern. There are 5 components to suicide: ideation, intent, plan, access to lethal means, and history of past suicide attempts. Suicide risk management refers to the identification, assessment, and treatment of a person exhibiting suicidal behaviour (includes death by suicide, suicide attempt, and suicidal ideation). Suicide risk management is an ongoing process in the treatment of a person who has

2018 BMJ Best Practice

14. NOACs and Antidepressants ? What are the risks of using these together and how should these risks be managed?

NOACs and Antidepressants ? What are the risks of using these together and how should these risks be managed? NOACs and Antidepressants – What are the risks of using these together and how should these risks be managed? – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice Menu · · Published 20th December 2018, updated 20th December 2018 This article considers the risk of interactions between NOACs and antidepressants. · Non-vitamin K antagonist oral (...) in anticoagulant effect. · See individual drug sections within the main text of this Q&A for NOAC manufacturers’ comments regarding their concomitant use with SJW. · The release of serotonin by platelets is important for maintaining haemostasis. SSRIs and SNRIs inhibit the serotonin transporter responsible for the uptake of serotonin into platelets. Thus SSRIs and SNRIs may increase the risk of bleeding. · Co-administration of NOACs with drugs that affect haemostasis, such as SSRIs or SNRIs, increases the risk

2019 Specialist Pharmacy Services

15. Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk Management

Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk Management No. 197c-Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk Management - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 4, Pages e353–e358 No. 197c-Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk (...) Management x Robert Liston , MD Vancouver, BC x Diane Sawchuck , RNm PhD Vancouver, BC x David Young , MD Halifax, NS No. 197c (Replaces No. 90 and No. 112), September 2007 (Reaffirmed April 2018) DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Disclaimer: This guideline has been reaffirmed for continued use until further notice. Key Words: , , , , , , , , , , To access this article, please choose from the options below Log In Register

2018 Society of Obstetricians and Gynaecologists of Canada

16. Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory

Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory EXPERT CONSENSUS DECISION PATHWAY 2019 ACC Expert Consensus Decision PathwayonRiskAssessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee Writing Committee Steven M. Hollenberg, MD, FACC, Chair Lynne Warner Stevenson, MD, FACC, Vice Chair Tariq Ahmad, MD, MPH, FACC Vaibhav J. Amin, MD (...) ,WarnerStevensonL,AhmadT,AminVJ,Bozkurt B, Butler J, Davis LL, Drazner MH, Kirkpatrick JN, Peterson PN, Reed BN, Roy CL, Storrow AB. 2019 ACC expert consensus decision pathway on risk assessment,management,andclinicaltrajectoryofpatientshospitalizedwithheartfailure:areportoftheAmericanCollegeofCardiologySolutionSet Oversight Committee. J Am Coll Cardiol 2019;XX:XXX–XX. Copies: This document is available on the World Wide Web site of the American College of Cardiology (www.acc.org). For copies of this document

2019 American College of Cardiology

17. Management of Infants at Risk for Group B Streptococcal Disease

in detail in the current AAP clinical reports on management of neonates with suspected or proven early-onset bacterial sepsis. , In summary, at this time, evidence supports the following: The ACOG provides guidance regarding intraamniotic infection ; neonatal risk assessment can be informed by this guidance. The definitive diagnosis of intraamniotic infection is that made by amniotic fluid Gram-stain and/or culture or by placental histopathologic testing. Such clear diagnostic information will rarely (...) Management of Infants at Risk for Group B Streptococcal Disease Management of Infants at Risk for Group B Streptococcal Disease | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact on clinical care. Management

2019 American Academy of Pediatrics

18. Diagnosis and management of patients at risk of gastric adenocarcinoma Full Text available with Trip Pro

guideline Process. The purpose of the guideline was to provide guidance to healthcare professionals who are involved in the care of patients at risk of gastric cancer, including gastroenterologists, GI surgeons, pathologists, endoscopists and general practitioners. The AGREE II instrument (May 2009) was used to guide the methodology. The chair (MB) convened a guideline development group (GDG), consisting of clinicians and patients with experience of, or in the management of, these conditions. Members (...) Diagnosis and management of patients at risk of gastric adenocarcinoma British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma | Gut We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers

2019 British Society of Gastroenterology

19. Assessment and Management of Patients at Risk for Suicide

Assessment and Management of Patients at Risk for Suicide VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE ASSESSMENT AND MANAGEMENT OF PATIENTS AT RISK FOR SUICIDE Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define a standard (...) of recommendations for specific testing and/or therapeutic interventions within these guidelines does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor. Version 2.0 – 2019VA/DoD Clinical Practice Guideline for the Assessment and Management of Patients at Risk for Suicide May 2019 Page 2 of 142 Prepared by: The Assessment and Management of Suicide Risk Work Group

2019 VA/DoD Clinical Practice Guidelines

20. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy Full Text available with Trip Pro

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy - Heart Rhythm Email/Username: Password: Remember me Search both HRS Journals Search Terms Search within Search Access provided by Volume 16, Issue 11, Pages e301–e372 2019 HRS expert consensus statement on evaluation, risk stratification, and management (...) the clinician with guidance on evaluation and management of ACM and includes clinically relevant information on genetics and disease mechanisms. PICO questions were utilized to evaluate contemporary evidence and provide clinical guidance related to exercise in arrhythmogenic right ventricular cardiomyopathy. Recommendations were developed and approved by an expert writing group, after a systematic literature search with evidence tables, and discussion of their own clinical experience, to present the current

2019 International Society for Heart and Lung Transplantation

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>